Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Clinical trial NCT04431024 · RECRUITING

Trial details

NCT number: NCT04431024
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Study type: OBSERVATIONAL

Familial Cancer BRCA1-Associated Protein-1 (BAP1) Mutations Tumor Predisposition Syndrome (TPDS)Mesothelioma

Start date: 2021-03-30
Primary completion: 2038-06-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.